Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial Agents and Chemotherapy 2005-07, Vol.49 (7), p.2802-2806
Hauptverfasser: Adkison, Kimberly K, Shachoy-Clark, Anne, Fang, Lei, Lou, Yu, O'Mara, Kathy, Berrey, M. Michelle, Piscitelli, Stephen C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2806
container_issue 7
container_start_page 2802
container_title Antimicrobial Agents and Chemotherapy
container_volume 49
creator Adkison, Kimberly K
Shachoy-Clark, Anne
Fang, Lei
Lou, Yu
O'Mara, Kathy
Berrey, M. Michelle
Piscitelli, Stephen C
description Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
doi_str_mv 10.1128/AAC.49.7.2802-2806.2005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_15980352</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17637013</sourcerecordid><originalsourceid>FETCH-LOGICAL-a547t-d97aa8cbaf3fc22c142f927174373dce80fbfc5a0e5fb2f2fb2c4171059e10f93</originalsourceid><addsrcrecordid>eNqNkcGP1CAYxRujccfVf0HxoKftCBRKuZhMJuqabNQ465l8pTBlbMsu0DXz38tkJo7evHyE8HvvAa8oXhG8JIQ271ar9ZLJpVjSBtMyj3pJMeaPigXBsilrLuvHxQLjui5Zg9lF8SzGHc57LvHT4oJw2eCK00XRfeshjKD9TzeZ5HREMHVo0_uQylsTRrQBa9IeeYsaURGGrxCgL_7BDGi9_s7Rakqw9ZOL6Qq5CV0bGFK_R6tuHhLazO3O6BSfF08sDNG8OK2XxY-PH27X1-XN10-f16ubEjgTqeykAGh0C7aymlJNGLWSCiJYJapOmwbb1moO2HDbUkvz0IwIgrk0BFtZXRbvj753czuarJhSgEHdBTdC2CsPTv17Mrlebf2DIqRuasmzwduTQfD3s4lJjS5qMwwwGT9HRURdCUyqDIojqIOPMRj7J4RgdWhI5YYUk0qoQ0OHUatDQ1nJjkqII1U7P4cpf8l_yF7-_bRz3KnJDLw5ARA1DDbApF08c7Uk2ZFl7vWR6922_-WCUfkiCkCfY6vfZS2z8A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17637013</pqid></control><display><type>article</type><title>Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Adkison, Kimberly K ; Shachoy-Clark, Anne ; Fang, Lei ; Lou, Yu ; O'Mara, Kathy ; Berrey, M. Michelle ; Piscitelli, Stephen C</creator><creatorcontrib>Adkison, Kimberly K ; Shachoy-Clark, Anne ; Fang, Lei ; Lou, Yu ; O'Mara, Kathy ; Berrey, M. Michelle ; Piscitelli, Stephen C</creatorcontrib><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.49.7.2802-2806.2005</identifier><identifier>PMID: 15980352</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Adolescent ; Adult ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral Agents ; Benzoates ; Benzoates - administration &amp; dosage ; Benzoates - adverse effects ; Benzoates - metabolism ; Benzoates - pharmacokinetics ; Biological and medical sciences ; CCR5 Receptor Antagonists ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug Administration Schedule ; Female ; Food-Drug Interactions ; HIV Fusion Inhibitors ; HIV Fusion Inhibitors - administration &amp; dosage ; HIV Fusion Inhibitors - adverse effects ; HIV Fusion Inhibitors - metabolism ; HIV Fusion Inhibitors - pharmacokinetics ; Humans ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Piperazines ; Spiro Compounds ; Spiro Compounds - administration &amp; dosage ; Spiro Compounds - adverse effects ; Spiro Compounds - metabolism ; Spiro Compounds - pharmacokinetics</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2005-07, Vol.49 (7), p.2802-2806</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright © 2005 American Society for Microbiology</rights><rights>Copyright © 2005, American Society for Microbiology 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a547t-d97aa8cbaf3fc22c142f927174373dce80fbfc5a0e5fb2f2fb2c4171059e10f93</citedby><cites>FETCH-LOGICAL-a547t-d97aa8cbaf3fc22c142f927174373dce80fbfc5a0e5fb2f2fb2c4171059e10f93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1168695/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1168695/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16918024$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15980352$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adkison, Kimberly K</creatorcontrib><creatorcontrib>Shachoy-Clark, Anne</creatorcontrib><creatorcontrib>Fang, Lei</creatorcontrib><creatorcontrib>Lou, Yu</creatorcontrib><creatorcontrib>O'Mara, Kathy</creatorcontrib><creatorcontrib>Berrey, M. Michelle</creatorcontrib><creatorcontrib>Piscitelli, Stephen C</creatorcontrib><title>Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><subject>Adolescent</subject><subject>Adult</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral Agents</subject><subject>Benzoates</subject><subject>Benzoates - administration &amp; dosage</subject><subject>Benzoates - adverse effects</subject><subject>Benzoates - metabolism</subject><subject>Benzoates - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>CCR5 Receptor Antagonists</subject><subject>Dose-Response Relationship, Drug</subject><subject>Double-Blind Method</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Food-Drug Interactions</subject><subject>HIV Fusion Inhibitors</subject><subject>HIV Fusion Inhibitors - administration &amp; dosage</subject><subject>HIV Fusion Inhibitors - adverse effects</subject><subject>HIV Fusion Inhibitors - metabolism</subject><subject>HIV Fusion Inhibitors - pharmacokinetics</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperazines</subject><subject>Spiro Compounds</subject><subject>Spiro Compounds - administration &amp; dosage</subject><subject>Spiro Compounds - adverse effects</subject><subject>Spiro Compounds - metabolism</subject><subject>Spiro Compounds - pharmacokinetics</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcGP1CAYxRujccfVf0HxoKftCBRKuZhMJuqabNQ465l8pTBlbMsu0DXz38tkJo7evHyE8HvvAa8oXhG8JIQ271ar9ZLJpVjSBtMyj3pJMeaPigXBsilrLuvHxQLjui5Zg9lF8SzGHc57LvHT4oJw2eCK00XRfeshjKD9TzeZ5HREMHVo0_uQylsTRrQBa9IeeYsaURGGrxCgL_7BDGi9_s7Rakqw9ZOL6Qq5CV0bGFK_R6tuHhLazO3O6BSfF08sDNG8OK2XxY-PH27X1-XN10-f16ubEjgTqeykAGh0C7aymlJNGLWSCiJYJapOmwbb1moO2HDbUkvz0IwIgrk0BFtZXRbvj753czuarJhSgEHdBTdC2CsPTv17Mrlebf2DIqRuasmzwduTQfD3s4lJjS5qMwwwGT9HRURdCUyqDIojqIOPMRj7J4RgdWhI5YYUk0qoQ0OHUatDQ1nJjkqII1U7P4cpf8l_yF7-_bRz3KnJDLw5ARA1DDbApF08c7Uk2ZFl7vWR6922_-WCUfkiCkCfY6vfZS2z8A</recordid><startdate>20050701</startdate><enddate>20050701</enddate><creator>Adkison, Kimberly K</creator><creator>Shachoy-Clark, Anne</creator><creator>Fang, Lei</creator><creator>Lou, Yu</creator><creator>O'Mara, Kathy</creator><creator>Berrey, M. Michelle</creator><creator>Piscitelli, Stephen C</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20050701</creationdate><title>Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects</title><author>Adkison, Kimberly K ; Shachoy-Clark, Anne ; Fang, Lei ; Lou, Yu ; O'Mara, Kathy ; Berrey, M. Michelle ; Piscitelli, Stephen C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a547t-d97aa8cbaf3fc22c142f927174373dce80fbfc5a0e5fb2f2fb2c4171059e10f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral Agents</topic><topic>Benzoates</topic><topic>Benzoates - administration &amp; dosage</topic><topic>Benzoates - adverse effects</topic><topic>Benzoates - metabolism</topic><topic>Benzoates - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>CCR5 Receptor Antagonists</topic><topic>Dose-Response Relationship, Drug</topic><topic>Double-Blind Method</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Food-Drug Interactions</topic><topic>HIV Fusion Inhibitors</topic><topic>HIV Fusion Inhibitors - administration &amp; dosage</topic><topic>HIV Fusion Inhibitors - adverse effects</topic><topic>HIV Fusion Inhibitors - metabolism</topic><topic>HIV Fusion Inhibitors - pharmacokinetics</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperazines</topic><topic>Spiro Compounds</topic><topic>Spiro Compounds - administration &amp; dosage</topic><topic>Spiro Compounds - adverse effects</topic><topic>Spiro Compounds - metabolism</topic><topic>Spiro Compounds - pharmacokinetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adkison, Kimberly K</creatorcontrib><creatorcontrib>Shachoy-Clark, Anne</creatorcontrib><creatorcontrib>Fang, Lei</creatorcontrib><creatorcontrib>Lou, Yu</creatorcontrib><creatorcontrib>O'Mara, Kathy</creatorcontrib><creatorcontrib>Berrey, M. Michelle</creatorcontrib><creatorcontrib>Piscitelli, Stephen C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adkison, Kimberly K</au><au>Shachoy-Clark, Anne</au><au>Fang, Lei</au><au>Lou, Yu</au><au>O'Mara, Kathy</au><au>Berrey, M. Michelle</au><au>Piscitelli, Stephen C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2005-07-01</date><risdate>2005</risdate><volume>49</volume><issue>7</issue><spage>2802</spage><epage>2806</epage><pages>2802-2806</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>15980352</pmid><doi>10.1128/AAC.49.7.2802-2806.2005</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial Agents and Chemotherapy, 2005-07, Vol.49 (7), p.2802-2806
issn 0066-4804
1098-6596
language eng
recordid cdi_pubmed_primary_15980352
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adolescent
Adult
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral Agents
Benzoates
Benzoates - administration & dosage
Benzoates - adverse effects
Benzoates - metabolism
Benzoates - pharmacokinetics
Biological and medical sciences
CCR5 Receptor Antagonists
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Food-Drug Interactions
HIV Fusion Inhibitors
HIV Fusion Inhibitors - administration & dosage
HIV Fusion Inhibitors - adverse effects
HIV Fusion Inhibitors - metabolism
HIV Fusion Inhibitors - pharmacokinetics
Humans
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Piperazines
Spiro Compounds
Spiro Compounds - administration & dosage
Spiro Compounds - adverse effects
Spiro Compounds - metabolism
Spiro Compounds - pharmacokinetics
title Pharmacokinetics and Short-Term Safety of 873140, a Novel CCR5 Antagonist, in Healthy Adult Subjects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A38%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20and%20Short-Term%20Safety%20of%20873140,%20a%20Novel%20CCR5%20Antagonist,%20in%20Healthy%20Adult%20Subjects&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=Adkison,%20Kimberly%20K&rft.date=2005-07-01&rft.volume=49&rft.issue=7&rft.spage=2802&rft.epage=2806&rft.pages=2802-2806&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.49.7.2802-2806.2005&rft_dat=%3Cproquest_pubme%3E17637013%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17637013&rft_id=info:pmid/15980352&rfr_iscdi=true